Public education and understanding of the role and business practices of PBMs is critically important for ensuring that New Hampshirites and our state government pay
no more than is absolutely
necessary for prescription drugs.
PBMs should compete transparently on the basis of cost to Granite Staters; this will maximize the benefit to patients, taxpayers, and group purchasers (including our state government).
PBMs should be accountable for delivering the highest possible savings – that is, the most affordable prescription drug pricing – to New Hampshire group purchasers and individual patients.
The lion’s share of financial savings that PBM middlemen and claims processors produce should flow directly to patients, health plan beneficiaries, and taxpayers.